Protocol No.: A012103

OptimICE-pCR: De-Escalation of Therapy in Early-Stage TNBC Patients who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy
Principal Investigator
Safi, Danish
Phase
III
Age Group
Adult
Applicable Disease Site
Breast Cancer
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
United Hospital Center
Contacts
Sabrina Rexroad, RN
Research Nurse
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585
Nnennaya Opara
Clinical Research Specialist
Phone: +1 681-342-1000
Kaitlyn Hager
Research Nurse

View on ClinicalTrials.gov